Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease
Human Molecular Genetics · 20.07.2023 · 32 (15) · 2441-2454
DOI: 10.1093/hmg/ddad069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 03.05.2023. Verfasst von Sumudu S C Amarasekera und 18 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia. Hauptthemen laut MEDLINE: Leigh Disease, Mitochondrial Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, Howard Hughes Medical Institute, Australian National Health and Medical Research Council.
Abstract (Originalsprache)
MRPL39 encodes one of 52 proteins comprising the large subunit of the mitochondrial ribosome (mitoribosome). In conjunction with 30 proteins in the small subunit, the mitoribosome synthesizes the 13 subunits of the mitochondrial oxidative phosphorylation (OXPHOS) system encoded by mitochondrial Deoxyribonucleic acid (DNA). We used multi-omics and gene matching to identify three unrelated individuals with biallelic variants in MRPL39 presenting with multisystem diseases with severity ranging from lethal, infantile-onset (Leigh syndrome spectrum) to milder with survival into adulthood. Clinical exome sequencing of known disease genes failed to diagnose these patients; however quantitative proteomics identified a specific decrease in the abundance of large but not small mitoribosomal subunits in fibroblasts from the two patients with severe phenotype. Re-analysis of exome sequencing led to the identification of candidate single heterozygous variants in mitoribosomal genes MRPL39 (both patients) and MRPL15. Genome sequencing identified a shared deep intronic MRPL39 variant predicted to generate a cryptic exon, with transcriptomics and targeted studies providing further functional evidence for causation. The patient with the milder disease was homozygous for a missense variant identified through trio exome sequencing. Our study highlights the utility of quantitative proteomics in detecting protein signatures and in characterizing gene-disease associations in exome-unsolved patients. We describe Relative Complex Abundance analysis of proteomics data, a sensitive method that can identify defects in OXPHOS disorders to a similar or greater sensitivity to the traditional enzymology. Relative Complex Abundance has potential utility for functional validation or prioritization in many hundreds of inherited rare diseases where protein complex assembly is disrupted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
- Department of Paediatrics, University of Melbourne, Melbourne, VIC 3010, Australia.
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.
- Department of Genetics, Yale School of Medicine, New Haven, CT 06510 USA.
- Broad Institute, Cambridge, MA 02142, USA.
- Howard Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Förderung
- NHGRI NIH HHS
- Howard Hughes Medical Institute
- Australian National Health and Medical Research Council
- US Department of Defense Congressionally Directed Medical Research Programs
- Australian Mito Foundation
- Vincent Chiodo Charitable Trust and the Victorian Government’s Operational Infrastructure Support Program
- Royal Children's Hospital Foundation
- Bio21 Mass Spectrometry and Proteomics Facility
Zitieren
APA
Amarasekera, S. S. C., Hock, D. H., Lake, N. J., Calvo, S. E., Grønborg, S. W., Krzesinski, E. I., Amor, D. J., Fahey, M. C., Simons, C., Wibrand, F., Mootha, V. K., Lek, M., Lunke, S., Stark, Z., Østergaard, E., Christodoulou, J., Thorburn, D. R., Stroud, D. A., & Compton, A. G. (2023). Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. Human Molecular Genetics, 32(15), 2441-2454. https://doi.org/10.1093/hmg/ddad069
Vancouver
Amarasekera SSC, Hock DH, Lake NJ, Calvo SE, Grønborg SW, Krzesinski EI, et al. Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. Human Molecular Genetics. 2023;32(15):2441-2454. doi:10.1093/hmg/ddad069
BibTeX
@article{Amarasekera2023,
author = {Amarasekera, Sumudu S C and Hock, Daniella H and Lake, Nicole J and Calvo, Sarah E and Grønborg, Sabine W and Krzesinski, Emma I and Amor, David J and Fahey, Michael C and Simons, Cas and Wibrand, Flemming and Mootha, Vamsi K and Lek, Monkol and Lunke, Sebastian and Stark, Zornitza and Østergaard, Elsebet and Christodoulou, John and Thorburn, David R and Stroud, David A and Compton, Alison G},
title = {Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease},
journal = {Human Molecular Genetics},
year = {2023},
volume = {32},
number = {15},
pages = {2441--2454},
doi = {10.1093/hmg/ddad069}
}
EUVIMED